Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|July 6, 2023
Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapyTeng Tu, Hongying Zhang, Huanji Xu
Heliyon|June 30, 2023
Inhibition of stress proteins TRIB3 and STC2 potentiates sorafenib sensitivity in hepatocellular carcinomaSheng Zhou, Huanji Xu, Tianhong Wei
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|May 11, 2018
[A β-catenin/IQGAP1 regulatory feedback loop and its effects on the proliferation of colon cancer cells]Huanji Xu, Hongwei Xia, Qiulin Tang, et al.
Precision Clinical Medicine|June 13, 2022
Apatinib treatment for unresectable gastrointestinal stromal tumor with synchronous gastric cancerHuanji Xu, Sheng Zhou, Qiancheng Hu, et al.
Anti-Cancer Drugs|March 6, 2021
The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cellsHuan Zhang, Huanji Xu, Qiulin Tang, et al.
Frontiers in Cell and Developmental Biology|November 10, 2025
A case report: enhanced somatostatin receptor expression in metastatic pancreatic neuroendocrine tumor following everolimus therapyPei Zhang, Chenyan Zhang, Huanji Xu, et al.
Frontiers in Immunology|May 29, 2026
Serplulimab combined with gemcitabine, nab-paclitaxel, and stereotactic body radiotherapy versus gemcitabine and nab-paclitaxel as first-line treatment for recurrent or metastatic pancreatic ductal adenocarcinoma: a randomized, open-label, multicenter, phase III clinical trial (WGOG-PAN 006/ICSBR-2)Xin Wang, Pei Zhang, Dan Cao, et al.
Frontiers in Pharmacology|June 29, 2026
Safety and efficacy of the MNK/VEGFR inhibitor JDB153 combined with the anti-PD-1 antibody serplulimab in patients with advanced pancreatic cancer refractory to standard treatment: a single-arm, phase Ib/II study protocolXiaorui Zhu, Hao Wei, Dan Cao, et al.
Molecular Cancer Therapeutics|September 27, 2019
Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK PathwaySheng Zhou, Huanji Xu, Qiulin Tang, et al.
Tumori|December 21, 2020
Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case reportHuanji Xu, Xin Wang, Sheng Zhou, et al.
Pageof 5